Effect of Moringa Oleifera Leaves on Glycemic Control of Women With Type 2 Diabetes
- Conditions
- Type 2 Diabetes
- Interventions
- Dietary Supplement: Supplementation of Moringa oleifera leaf powder
- Registration Number
- NCT06517602
- Lead Sponsor
- University of Milan
- Brief Summary
The objective of this clinical trial was to understand whether supplementation of Moringa oleifera leaf powder improved glycemic management in Sahrawi women with type 2 diabetes living in refugee camps. The main question sought to be answered was:
- Does daily supplementation of Moringa oleifera leaf powder, in addition to oral hypoglycemic therapy, improve glycosylated hemoglobin and fasting blood glucose?
Researchers compared Moringa supplementation with no Moringa consumption to see if Moringa oleifera worked to improve glycemic control.
Participants had to:
* Take Moringa oleifera leaves daily or abstain from consuming Moringa for 3 months.
* Consistently take prescribed oral hypoglycemic agents
* Undergo clinical examinations and measurement of biochemical, metabolic and body composition parameters at the time of recruitment and at the end of the study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 52
- Diagnosis of type 2 diabetes for at least 1 year
- Absence of advanced retinopathy, terminal renal failure, active diabetic ulcers, amputations, and heart failure
- Treatment with only oral hypoglycemic drugs.
- Diagnosis of type 1 diabetes
- Pregnancy or lactation
- Treatment with insulin.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Moringa Supplementation of Moringa oleifera leaf powder The experimental group received for 3 months a daily supplementation of 10g of Moringa oleifera leaf powder to consume within the two main meals.
- Primary Outcome Measures
Name Time Method Fasting glucose Fasting glucose was measured at recruitment and at the end of the study (three months) Glycosylated hemoglobin (HbA1c) Glycosylated hemoglobin was measured at recruitment and at the end of the study (three months)
- Secondary Outcome Measures
Name Time Method Hip circumference Hip circumference were measured at recruitment and at the end of the study (3 months) BMI BMI were measured at recruitment and at the end of the study (3 months) Waist circumference Waist circumference were measured at recruitment and at the end of the study (3 months) % body fat % of body fat were measured at recruitment and at the end of the study (3 months) Blood pressure Systolic and diastolic blood pressure were measured at recruitment and at the end of the study (3 months) Systolic and diastolic blood pressure
Trial Locations
- Locations (1)
Dispensaris of Edchedería, Bir Lehlu, Mahbes, and Farsia (Smara camp)
🇩🇿Tindouf, Algeria